Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES CIPLA DIVIS LABORATORIES/
CIPLA
 
P/E (TTM) x 31.5 35.2 89.4% View Chart
P/BV x 8.3 4.3 192.7% View Chart
Dividend Yield % 0.8 0.4 181.6%  

Financials

 DIVIS LABORATORIES   CIPLA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-22
CIPLA
Mar-22
DIVIS LABORATORIES/
CIPLA
5-Yr Chart
Click to enlarge
High Rs5,4251,083 500.9%   
Low Rs3,562806 441.8%   
Sales per share (Unadj.) Rs337.5269.7 125.1%  
Earnings per share (Unadj.) Rs111.531.7 351.5%  
Cash flow per share (Unadj.) Rs123.344.8 275.4%  
Dividends per share (Unadj.) Rs30.005.00 600.0%  
Avg Dividend yield %0.70.5 126.1%  
Book value per share (Unadj.) Rs441.8257.8 171.4%  
Shares outstanding (eoy) m265.47806.81 32.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x13.33.5 380.2%   
Avg P/E ratio x40.329.8 135.3%  
P/CF ratio (eoy) x36.521.1 172.7%  
Price / Book Value ratio x10.23.7 277.5%  
Dividend payout %26.915.8 170.7%   
Avg Mkt Cap Rs m1,192,890762,177 156.5%   
No. of employees `000NANA-   
Total wages/salary Rs m9,46235,299 26.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m89,598217,633 41.2%  
Other income Rs m1,1593,217 36.0%   
Total revenues Rs m90,757220,851 41.1%   
Gross profit Rs m38,81143,298 89.6%  
Depreciation Rs m3,11510,520 29.6%   
Interest Rs m201,064 1.9%   
Profit before tax Rs m36,83534,933 105.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2319,338 77.4%   
Profit after tax Rs m29,60525,595 115.7%  
Gross profit margin %43.319.9 217.7%  
Effective tax rate %19.626.7 73.4%   
Net profit margin %33.011.8 281.0%  
BALANCE SHEET DATA
Current assets Rs m96,104147,108 65.3%   
Current liabilities Rs m24,54449,129 50.0%   
Net working cap to sales %79.945.0 177.4%  
Current ratio x3.93.0 130.8%  
Inventory Days Days963 13.9%  
Debtors Days Days9876 17,192.8%  
Net fixed assets Rs m50,087119,415 41.9%   
Share capital Rs m5311,614 32.9%   
"Free" reserves Rs m116,751206,364 56.6%   
Net worth Rs m117,282207,977 56.4%   
Long term debt Rs m04,162 0.0%   
Total assets Rs m146,191266,523 54.9%  
Interest coverage x1,842.833.8 5,444.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.8 75.1%   
Return on assets %20.310.0 202.6%  
Return on equity %25.212.3 205.1%  
Return on capital %31.417.0 185.2%  
Exports to sales %026.2 0.0%   
Imports to sales %19.78.2 241.2%   
Exports (fob) Rs mNA57,094 0.0%   
Imports (cif) Rs m17,67617,803 99.3%   
Fx inflow Rs m78,44560,180 130.4%   
Fx outflow Rs m17,95317,803 100.8%   
Net fx Rs m60,49242,376 142.8%   
CASH FLOW
From Operations Rs m19,11833,259 57.5%  
From Investments Rs m-21,949-18,719 117.3%  
From Financial Activity Rs m-5,324-15,998 33.3%  
Net Cashflow Rs m-8,156-1,323 616.4%  

Share Holding

Indian Promoters % 51.9 13.5 385.0%  
Foreign collaborators % 0.0 20.1 -  
Indian inst/Mut Fund % 36.5 49.0 74.5%  
FIIs % 16.5 27.6 59.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 66.4 72.4%  
Shareholders   346,905 418,910 82.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    


More on Divis Laboratories vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs Cipla Share Price Performance

Period Divis Laboratories Cipla S&P BSE HEALTHCARE
1-Day -0.25% -0.22% 0.67%
1-Month 1.64% 7.34% 1.42%
1-Year -23.22% 13.32% -10.55%
3-Year CAGR 30.32% 37.92% 23.16%
5-Year CAGR 33.89% 13.95% 11.48%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of Cipla the stake stands at 33.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 26.9%.

Cipla paid Rs 5.0, and its dividend payout ratio stood at 15.8%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

3 Reasons Why Sensex Rallied 1,016 Points Today(Closing)

After opening the day on a strong note, Indian share markets extended gains as the session progressed and ended near day's high.